Počet záznamov: 1
testy karcinogenity
SYS d015197 LBL 00000nz--a2200000o--4500 005 20250606213302.6 008 920423|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a E05.940.150 066 $a 01 $c 03 150 $a testy karcinogenity $x AE $x CL $x EC $x ES $x HI $x IS $x MO $x MT $x NU $x PX $x SN $x ST $x TD $x VE $2 slo 450 $w v $a Tumorigenicity Tests $2 eng 450 $w v $a testy tumorogénnosti $2 slo 550 $7 sllk_us_auth*d009152 $Y Mutagenicity Tests $w b $a testy mutagenity 550 $7 sllk_us_auth*d009152 $Y Mutagenicity Tests $w p $a testy mutagenity 665 $a 89 $2 eng 665 $a Carcinogens (1966-1988) $2 eng 665 $a Mutagenicity Tests (1981-1988) $2 eng 680 9-
$i Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. $2 eng 680 $a NIM; Manual 24.5.6.2+ $2 eng 750 -2
$a Carcinogenicity Tests $2 eng 980 $x M
Počet záznamov: 1